Search

Anti-angiogenic therapy for kidney cancer

Anti-angiogenic therapy helps slow cancer growth by blocking the blood supply tumours need to grow. This section explains how it works, its benefits, and what to expect during treatment.

Understanding the treatment

Anti-angiogenic blocks the growth of blood vessels that feed the tumour. With fewer vessels, the tumour gets less oxygen and nutrients. This can slow growth or shrink the tumour.

This therapy is also called targeted therapy It blocks signals cancer cells use to survive and grow.

This chapter contains general information about anti-angiogenic therapy for kidney cancer. It is not a substitute for professional medical advice or treatment. Always consult your doctor or healthcare provider for guidance on your individual medical situation.

Last updated: September 2025

Reviewed by: 

  • Ms. Claudia Ungarelli (Patient Office EPAG)
  • Dr. Gaëlle Margue (YAU Working Group on Renal Cell Carcinoma)